(Q29006019)

English

Invokana

pharmaceutical product

In more languages

default for all languages

No label defined

No description defined

Statements

pharmaceutical product

1 reference

European Medicines Agency product number

EMEA/H/C/002649

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002649/human_med_001707.jsp

22 March 2017

1 reference

European Medicines Agency product number

EMEA/H/C/002649

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002649/human_med_001707.jsp

22 March 2017

has active ingredient

canagliflozin hemihydrate

1 reference

14 February 2018

therapeutic area

maturity-onset diabetes of the young type 2

European Medicines Agency

15 November 2013

1 reference

European Medicines Agency product number

EMEA/H/C/002649

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002649/human_med_001707.jsp

16 February 2017

European Medicines Agency

Identifiers

European Medicines Agency product number

EMEA/H/C/002649

1 reference

European Medicines Agency product number

EMEA/H/C/002649

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002649/human_med_001707.jsp

22 March 2017

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29006019&oldid=2012944964"